AU8253498A - Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases - Google Patents

Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Info

Publication number
AU8253498A
AU8253498A AU82534/98A AU8253498A AU8253498A AU 8253498 A AU8253498 A AU 8253498A AU 82534/98 A AU82534/98 A AU 82534/98A AU 8253498 A AU8253498 A AU 8253498A AU 8253498 A AU8253498 A AU 8253498A
Authority
AU
Australia
Prior art keywords
inhibition
treatment
compounds useful
proliferative diseases
protein function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU82534/98A
Inventor
Adriano Afonso
Joseph M. Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU8253498A publication Critical patent/AU8253498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU82534/98A 1997-06-17 1998-06-15 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases Abandoned AU8253498A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87726997A 1997-06-17 1997-06-17
US08877269 1997-06-17
PCT/US1998/011506 WO1998057964A1 (en) 1997-06-17 1998-06-15 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Publications (1)

Publication Number Publication Date
AU8253498A true AU8253498A (en) 1999-01-04

Family

ID=25369601

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82534/98A Abandoned AU8253498A (en) 1997-06-17 1998-06-15 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Country Status (2)

Country Link
AU (1) AU8253498A (en)
WO (1) WO1998057964A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
JP2875393B2 (en) * 1993-10-15 1999-03-31 シェーリング コーポレイション Tricyclic carbamate compounds useful for inhibiting G-protein function and treating proliferative disorders
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Pharmaceutical compositions for inhibition of g-protein function and for treatment of proliferative diseases containing tricyclic compounds some such compounds and process for preparing part of them
US5700806A (en) * 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117797A0 (en) * 1995-04-07 1996-08-04 Pharmacopeia Inc Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases and pharmaceutical compositions comprising them
US5712280A (en) * 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
WO1998057964A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
AU5527996A (en) Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
AU5307296A (en) Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
AU5189196A (en) Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
AU5307796A (en) Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
AU5307696A (en) Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
HK1025571A1 (en) Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
AU2092697A (en) Combinations for treatment of proliferative diseases
AU2912997A (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
AU6594796A (en) Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases
AU4398296A (en) Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
AU3634095A (en) Inhibition of hemoflagellates by camptothecin compounds
AU5901896A (en) Use of aryl-substituted cyclobutylalkylamines for treating obesity
AU8058498A (en) Carboxy piperidylacetamide tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors)
IL117797A0 (en) Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
HUP0102473A3 (en) Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
IL115320A0 (en) Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
AU2321692A (en) Materials and methods for enhanced photocatalyzation of organic compounds
AU9636598A (en) Treatment of organic materials
AU4546096A (en) Treatment of waste
AU8253498A (en) Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
AU5126298A (en) Inhibition of crib-biting
HK1002865A1 (en) Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
HUP9801338A3 (en) Use of tricyclic carbamate derivatives for inhibition of g-protein function and for treatment of proliferative diseases
AU4308699A (en) Use of anti-prolactin agents to treat proliferative conditions
ZA9610735B (en) Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase